Senate Confirms Sara Carter as New Drug Czar

On January 6, 2026, the U.S. Senate confirmed Sara A. Carter Bailey as the director of the Office of National Drug Control Policy (ONDCP) by a narrow vote of 52-48. Nominated by President Donald Trump in March 2025, Carter is the first woman to hold this position. Her confirmation comes amid a broader effort by the Trump administration to intensify the crackdown on drug trafficking and address the opioid crisis, particularly the surge in fentanyl-related overdoses.

Filter Magazine

Carter, a former Fox News contributor and investigative journalist, has spent over two decades reporting on drug trafficking and national security. She previously served as a special advisor to President Trump within the ONDCP starting in May 2025. Her work has focused on mapping drug trafficking routes and exposing cartel operations, particularly along the U.S.-Mexico border.

Sara Carter Confirmed as Director of Office of National Drug Control PolicySenate confirms Sara Carter as the Trump administration's new 'drug czar'Filter Magazine

As the ONDCP director, Carter is tasked with coordinating federal drug policy across law enforcement, public health, prevention, and treatment programs. She is expected to influence funding allocations for various drug-related initiatives, despite the Trump administration's significant cuts to ONDCP funding in its 2026 budget proposal, which reduced the office's budget by more than half.

Filter Magazine

Carter's rhetoric emphasizes a combative stance against drug traffickers, whom she describes as "narco-terrorists." Following her confirmation, she stated, “We will hold accountable the narco-terrorists who infringe upon this right, participating in the deliberate poisoning of tens of thousands of Americans each year.” This aligns with the administration's recent designations of fentanyl as a weapon of mass destruction and transnational drug-trafficking organizations as terrorist groups.

Filter Magazine

Carter's nomination faced opposition from Senate Democrats, who questioned her qualifications for the role. Critics have raised concerns about her history of promoting misinformation regarding fentanyl and immigration, particularly her claims about "fentanyl-laced" gummy bears. Despite this, she received endorsements from prominent figures, including Senator Marsha Blackburn (R-TN).

Filter Magazine

In contrast, some advocates for drug policy reform have expressed skepticism about her approach, fearing that her confirmation may perpetuate harmful narratives surrounding drug use and addiction.

Filter Magazine

• “I am honored and humbled to join President Trump’s Administration as Director of the Office of National Drug Control Policy.” — Sara Carter, ONDCP Director

Sara Carter Confirmed as Director of Office of National Drug Control Policy

• “We will provide every American with the tools and resources to protect themselves and their children from drug addiction- we're in this fight together, we can't win this alone," she added.” — Sara Carter, ONDCP Director

Senate confirms Sara Carter as the Trump administration's new 'drug czar'

Carter's leadership will be closely monitored as she implements her policies and navigates the complexities of drug control in the United States. Her stance on marijuana legalization, which she has expressed support for in medical contexts, may also influence future discussions on drug policy reform. As the ONDCP continues to evolve, the impact of Carter's confirmation on national drug strategy remains to be seen.

Filter Magazine